‹ ›
MYP_124793
← PREVIOUS NEXT → BACK
Basic Information
MDVgHH2L
Antimicrobial
Antiviral
Antiviral ▸ Antiviral mechanism ▸ Viral entry inhibition
Standard
39 amino acids
C177H306N50O59S
Standard
Sequence
NDSRGIDAEEELETKAELVITKLKTPLMRGKVVVGAAGA
Physicochemical Analysis
4110.69 Da
5.15
-1.23
-1.45
-0.0315
-0.17
0.56
-0.01
12.64
102.56
0.0000
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
1773.32
-18.07
61.0
59.0
144.0
287.0
1.0
39.0
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0009352 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
Marek's disease virus(MDV):inhibition of viral infection in chicken embryo fibroblasts
34±2 μM
IC50
PaperPubMed PMID: 24412629 PMID24412629 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24412629/
RECORD: Rec_0024710 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-MDV Entry inhibition
Marek's disease virus(MDV)
34±2 μM
IC50
Mammalian: 1.4 h; Yeast: 3 min; E. coli: >10 h
PaperIn vitro and in vivo broad antiviral activity of peptides homologous to fusion glycoproteins of Newcastle disease virus and Marek's disease virus. | Chi XJ, Wang XJ, Wang CY, Cui XJ, Wang XJ. | J Virol Methods. 2014 Apr;199:11-6. | DOI:10.1016/j.jviromet.2013.12.022 | PMID:24412629 PMID24412629 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24412629/
RECORD: Rec_0061601 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Synthetic peptide
32630
Structure & Mods
synthetic linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antiviral Anti-NDV Entry inhibition
Newcastle disease virus(NDV)
43.4±2 μM
IC50
Mammalian: 1.4 h; Yeast: 3 min; E. coli: >10 h
PaperIn vitro and in vivo broad antiviral activity of peptides homologous to fusion glycoproteins of Newcastle disease virus and Marek's disease virus. | Chi XJ, Wang XJ, Wang CY, Cui XJ, Wang XJ. | J Virol Methods. 2014 Apr;199:11-6. | DOI:10.1016/j.jviromet.2013.12.022 | PMID:24412629 PMID24412629 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24412629/
RECORD: Rec_0251990 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
PaperPubMed PMID: 24412629 PMID24412629 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24412629/
RECORD: Rec_0398089 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
None
None
Bio-Activity Profile
Antimicrobial Antiviral
Newcastle disease virus(NDV):inhibition of viral infection in chicken embryo fibroblasts
43.4±2 μM
IC50
PaperPubMed PMID: 24412629 PMID24412629 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/24412629/